Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Income from Continuing Operations (2016 - 2025)

Avanos Medical's Income from Continuing Operations history spans 11 years, with the latest figure at 5900000.0 for Q3 2024.

  • For Q3 2024, Income from Continuing Operations rose 167.05% year-over-year to 5900000.0; the TTM value through Sep 2024 reached 21700000.0, up 293.75%, while the annual FY2023 figure was 9900000.0, 146.05% down from the prior year.
  • Income from Continuing Operations for Q3 2024 was 5900000.0 at Avanos Medical, up from 4300000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 37800000.0 in Q2 2021 and bottomed at 49000000.0 in Q4 2020.
  • The 5-year median for Income from Continuing Operations is 3700000.0 (2020), against an average of 878947.37.
  • The largest annual shift saw Income from Continuing Operations crashed 703.28% in 2020 before it skyrocketed 1360.0% in 2021.
  • A 5-year view of Income from Continuing Operations shows it stood at 49000000.0 in 2020, then surged by 47.55% to 25700000.0 in 2021, then skyrocketed by 137.74% to 9700000.0 in 2022, then increased by 13.4% to 11000000.0 in 2023, then tumbled by 46.36% to 5900000.0 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Income from Continuing Operations are 5900000.0 (Q3 2024), 4300000.0 (Q2 2024), and 500000.0 (Q1 2024).